Discontinuation report BLEPHAMIDE S.O.P.
Report ID | 90343 |
Drug Identification Number | 00307246 |
Brand name | BLEPHAMIDE S.O.P. |
Common or Proper name | BLEPHAMIDE SOP 10%, 0.2% Oph Sol |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PREDNISOLONE ACETATE SULFACETAMIDE SODIUM |
Strength(s) | 0.2% 10% |
Dosage form(s) | OINTMENT |
Route of administration | OPHTHALMIC |
Packaging size | 3.5g |
ATC code | S01CA |
ATC description | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-07-15 |
Actual discontinuation date | 2019-07-15 |
Remaining supply date | 2019-07-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-07-31 | French | Compare |
v1 | 2019-07-31 | English | Compare |
Showing 1 to 2 of 2